Last 12 months
Inside the activity.
0 purchase rows · 57 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 33 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 18, 2020 Filed Nov 20, 2020 21:58 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 5,776 | $43.98 | $254,028.48 |
DisclosureSEC source: 0000904454-20-000781 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,067 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.65 to $44.33. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:58 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 3,937 | $43.11 | $169,724.07 |
DisclosureSEC source: 0000904454-20-000781 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,843 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.65 to $43.64. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:58 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
Exercise / conversionOrdinary Shares | 3,216 | $7.53 | $24,216.48 |
DisclosureSEC source: 0000904454-20-000781 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 14, 2020 Filed Oct 16, 2020 20:10 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 300 | $36.49 | $10,947.00 |
DisclosureSEC source: 0000904454-20-000661 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,564 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.38 to $36.58. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 14, 2020 Filed Oct 16, 2020 20:10 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 4,950 | $35.82 | $177,309.00 |
DisclosureSEC source: 0000904454-20-000661 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,864 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.35 to $36.34. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 21, 2020 Filed Sep 22, 2020 13:48 UTC |
Gut RobertDirector · Chief Medical Officer
|
SaleOrdinary Shares | 4,352 | $39.12 | $170,250.24 |
DisclosureSEC source: 0000904454-20-000624 · edgar.xml · nonDerivative · entry 1 Gut Robert · CIK 0001716268 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,523 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.84 to $39.72. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 18, 2020 Filed Sep 22, 2020 13:54 UTC |
Kuta Alexander Edward IIIExecutive VP, Operations
|
SaleOrdinary Shares | 2,230 | $41.18 | $91,831.40 |
DisclosureSEC source: 0000904454-20-000626 · edgar.xml · nonDerivative · entry 1 Kuta Alexander Edward III · CIK 0001696698 · Executive VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,860 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.93 to $41.48. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 17:41 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 119 | $42.18 | $5,019.42 |
DisclosureSEC source: 0000904454-20-000620 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,814 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.17 to $42.18. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 17:41 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 2,129 | $41.31 | $87,948.99 |
DisclosureSEC source: 0000904454-20-000620 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,933 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.95 to $41.89. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 17:41 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 5,252 | $40.36 | $211,970.72 |
DisclosureSEC source: 0000904454-20-000620 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,062 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.95 to $40.94. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 16:28 UTC |
POST LEONARD EDirector
|
GrantStock option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $38.67 | $0.00 |
DisclosureSEC source: 0000904454-20-000614 · edgar.xml · derivative · entry 1 POST LEONARD E · CIK 0001235862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2030-09-15 F1 · derivative.exercise_date: The Stock Option vests over three years, with 33.33% vesting after twelve months from the date of grant and then 8.33% every three months thereafter, subject to the Reporting Person's continued relationship with the Issuer through each such date. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 20:38 UTC |
Dolmetsch RicardoPresident
|
GrantStock option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $38.67 | $0.00 |
DisclosureSEC source: 0000904454-20-000618 · edgar.xml · derivative · entry 3 Dolmetsch Ricardo · CIK 0001825206 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Ordinary Shares · 35,000 shares Expires 2030-09-15 F3 · derivative.exercise_date: The Stock Option vests over four years, with 25% vesting after twelve months from the date of grant and then 6.25% every three months thereafter, subject to the Reporting Person's continued relationship with the Issuer through each such date. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 20:38 UTC |
Dolmetsch RicardoPresident
|
GrantOrdinary Shares | 55,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-20-000618 · edgar.xml · nonDerivative · entry 2 Dolmetsch Ricardo · CIK 0001825206 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 F2 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments over three years, subject to the Reporting Person's continued relationship with the Issuer through each such date. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 20:38 UTC |
Dolmetsch RicardoPresident
|
GrantOrdinary Shares | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-20-000618 · edgar.xml · nonDerivative · entry 1 Dolmetsch Ricardo · CIK 0001825206 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in full on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| August 25, 2020 Filed Aug 27, 2020 21:00 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 300 | $40.27 | $12,081.00 |
DisclosureSEC source: 0000904454-20-000606 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,314 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.24 to $40.30. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:32 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 1,150 | $40.18 | $46,207.00 |
DisclosureSEC source: 0000904454-20-000594 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,614 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.65 to $40.41. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:32 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 3,150 | $38.72 | $121,968.00 |
DisclosureSEC source: 0000904454-20-000594 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,764 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.30 to $39.29. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 22, 2020 Filed Jul 24, 2020 20:41 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 611 | $43.03 | $26,291.33 |
DisclosureSEC source: 0000904454-20-000511 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,914 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.95 to $43.11. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 22, 2020 Filed Jul 24, 2020 20:41 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 5,015 | $42.22 | $211,733.30 |
DisclosureSEC source: 0000904454-20-000511 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,525 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.83 to $42.75. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 23, 2020 Filed Jun 24, 2020 20:21 UTC |
Gut RobertDirector · Chief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 21,875 | $0.00 Strike: $39.97 | $0.00 |
DisclosureSEC source: 0000904454-20-000417 · edgar.xml · derivative · entry 5 Gut Robert · CIK 0001716268 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,125 Underlying: Ordinary Shares · 21,875 shares Expires 2028-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Stock Option vests over four years, with 25% vesting after twelve months from the date of grant (09/18/2018) and then 6.25% every three months thereafter, subject to the Reporting Person's continued relationship with the Issuer through each such date. Read SEC document |
| June 23, 2020 Filed Jun 24, 2020 20:21 UTC |
Gut RobertDirector · Chief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $35.40 | $0.00 |
DisclosureSEC source: 0000904454-20-000417 · edgar.xml · derivative · entry 4 Gut Robert · CIK 0001716268 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Ordinary Shares · 5,000 shares Expires 2028-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Stock Option vests over three years, with one-third vesting after twelve months from the date of grant (06/14/2018) and then one-twelfth every three months thereafter, subject to the Reporting Person's continued relationship with the Issuer through each such date. Read SEC document |
| June 23, 2020 Filed Jun 24, 2020 20:21 UTC |
Gut RobertDirector · Chief Medical Officer
|
SaleOrdinary Shares | 26,875 | $70.00 | $1,881,250.00 |
DisclosureSEC source: 0000904454-20-000417 · edgar.xml · nonDerivative · entry 3 Gut Robert · CIK 0001716268 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,875 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 23, 2020 Filed Jun 24, 2020 20:21 UTC |
Gut RobertDirector · Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 21,875 | $39.97 | $874,343.75 |
DisclosureSEC source: 0000904454-20-000417 · edgar.xml · nonDerivative · entry 2 Gut Robert · CIK 0001716268 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2020 Filed Jun 24, 2020 20:21 UTC |
Gut RobertDirector · Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 5,000 | $35.40 | $177,000.00 |
DisclosureSEC source: 0000904454-20-000417 · edgar.xml · nonDerivative · entry 1 Gut Robert · CIK 0001716268 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2020 Filed Jun 22, 2020 20:43 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 300 | $66.97 | $20,091.00 |
DisclosureSEC source: 0000904454-20-000415 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,540 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.94 to $66.99. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2020 Filed Jun 22, 2020 20:43 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 3,492 | $66.47 | $232,113.24 |
DisclosureSEC source: 0000904454-20-000415 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,840 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.93 to $66.86. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2020 Filed Jun 22, 2020 20:43 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 3,709 | $65.56 | $243,162.04 |
DisclosureSEC source: 0000904454-20-000415 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,332 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.93 to $65.92. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 20, 2020 Filed May 22, 2020 21:13 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 700 | $60.48 | $42,336.00 |
DisclosureSEC source: 0000904454-20-000379 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,041 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.31 to $60.74. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 20, 2020 Filed May 22, 2020 21:13 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 6,801 | $59.88 | $407,243.88 |
DisclosureSEC source: 0000904454-20-000379 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,741 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.37 to $60.28. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 24, 2020 Filed Apr 28, 2020 20:29 UTC |
KLEMT CHRISTIANChief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,250 | $0.00 Strike: $26.41 | $0.00 |
DisclosureSEC source: 0000904454-20-000328 · edgar.xml · derivative · entry 3 KLEMT CHRISTIAN · CIK 0001711885 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,250 shares Expires 2025-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Stock Option vested 25% on September 1, 2016 (the first anniversary of the date of grant), and vests 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| April 24, 2020 Filed Apr 28, 2020 20:29 UTC |
KLEMT CHRISTIANChief Accounting Officer
|
SaleOrdinary Shares | 2,250 | $60.00 | $135,000.00 |
DisclosureSEC source: 0000904454-20-000328 · edgar.xml · nonDerivative · entry 2 KLEMT CHRISTIAN · CIK 0001711885 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,018 F2 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| April 24, 2020 Filed Apr 28, 2020 20:29 UTC |
KLEMT CHRISTIANChief Accounting Officer
|
Exercise / conversionOrdinary Shares | 2,250 | $26.41 | $59,422.50 |
DisclosureSEC source: 0000904454-20-000328 · edgar.xml · nonDerivative · entry 1 KLEMT CHRISTIAN · CIK 0001711885 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 20:46 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,376 | $0.00 Strike: $7.53 | $0.00 |
DisclosureSEC source: 0000904454-20-000326 · edgar.xml · derivative · entry 4 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,659 Underlying: Ordinary Shares · 9,376 shares Expires 2026-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The Stock Option vested 25% on September 29, 2017 (the first anniversary of the date of grant), and vests 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 20:46 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 1,200 | $57.34 | $68,808.00 |
DisclosureSEC source: 0000904454-20-000326 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,542 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.19 to 58.00. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 20:46 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 8,176 | $56.80 | $464,396.80 |
DisclosureSEC source: 0000904454-20-000326 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,742 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.19 to $57.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 20:46 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
Exercise / conversionOrdinary Shares | 9,376 | $7.53 | $70,601.28 |
DisclosureSEC source: 0000904454-20-000326 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2020 Filed Mar 20, 2020 17:16 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,626 | $0.00 Strike: $7.53 | $0.00 |
DisclosureSEC source: 0000904454-20-000300 · edgar.xml · derivative · entry 6 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,035 Underlying: Ordinary Shares · 5,626 shares Expires 2026-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The Stock Option vested 25% on September 29, 2017 (the first anniversary of the date of grant), and vests 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 18, 2020 Filed Mar 20, 2020 17:16 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 200 | $43.70 | $8,740.00 |
DisclosureSEC source: 0000904454-20-000300 · edgar.xml · nonDerivative · entry 5 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,542 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.48 to $43.91. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 18, 2020 Filed Mar 20, 2020 17:16 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 1,438 | $42.40 | $60,971.20 |
DisclosureSEC source: 0000904454-20-000300 · edgar.xml · nonDerivative · entry 4 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,742 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.06 to $43.02. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 18, 2020 Filed Mar 20, 2020 17:16 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 2,100 | $41.45 | $87,045.00 |
DisclosureSEC source: 0000904454-20-000300 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,180 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.03 to 42.02. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 18, 2020 Filed Mar 20, 2020 17:16 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
SaleOrdinary Shares | 1,888 | $40.57 | $76,596.16 |
DisclosureSEC source: 0000904454-20-000300 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,280 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.02 to $40.97. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 18, 2020 Filed Mar 20, 2020 17:16 UTC |
Kapusta Matthew CDirector · CEO, CFO, Managing Director
|
Exercise / conversionOrdinary Shares | 5,626 | $7.53 | $42,363.78 |
DisclosureSEC source: 0000904454-20-000300 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 15:07 UTC |
KLEMT CHRISTIANChief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,750 | $0.00 Strike: $26.41 | $0.00 |
DisclosureSEC source: 0000904454-20-000277 · edgar.xml · derivative · entry 4 KLEMT CHRISTIAN · CIK 0001711885 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Ordinary Shares · 15,750 shares Expires 2025-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Stock Option vested 25% on September 1, 2016 (the first anniversary of the date of grant), and vests 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 15:07 UTC |
KLEMT CHRISTIANChief Accounting Officer
|
SaleOrdinary Shares | 2,250 | $54.00 | $121,500.00 |
DisclosureSEC source: 0000904454-20-000277 · edgar.xml · nonDerivative · entry 3 KLEMT CHRISTIAN · CIK 0001711885 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,018 F2 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 15:07 UTC |
KLEMT CHRISTIANChief Accounting Officer
|
SaleOrdinary Shares | 13,500 | $52.00 | $702,000.00 |
DisclosureSEC source: 0000904454-20-000277 · edgar.xml · nonDerivative · entry 2 KLEMT CHRISTIAN · CIK 0001711885 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,268 F2 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 15:07 UTC |
KLEMT CHRISTIANChief Accounting Officer
|
Exercise / conversionOrdinary Shares | 15,750 | $26.41 | $415,957.50 |
DisclosureSEC source: 0000904454-20-000277 · edgar.xml · nonDerivative · entry 1 KLEMT CHRISTIAN · CIK 0001711885 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,768 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 20:49 UTC |
Soteropoulos PaulaDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,620 | $0.00 Strike: $51.81 | $0.00 |
DisclosureSEC source: 0000904454-20-000259 · edgar.xml · derivative · entry 2 Soteropoulos Paula · CIK 0001692444 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,620 Underlying: Ordinary Shares · 3,620 shares Expires 2030-02-27 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 20:49 UTC |
Soteropoulos PaulaDirector
|
GrantOrdinary Shares | 2,063 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-20-000259 · edgar.xml · nonDerivative · entry 1 Soteropoulos Paula · CIK 0001692444 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,486 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 15:46 UTC |
SCHAFFER DAVIDDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,620 | $0.00 Strike: $51.81 | $0.00 |
DisclosureSEC source: 0000904454-20-000257 · edgar.xml · derivative · entry 2 SCHAFFER DAVID · CIK 0001692929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,620 Underlying: Ordinary Shares · 3,620 shares Expires 2030-02-27 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 15:46 UTC |
SCHAFFER DAVIDDirector
|
GrantOrdinary Shares | 2,063 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-20-000257 · edgar.xml · nonDerivative · entry 1 SCHAFFER DAVID · CIK 0001692929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,978 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.